Cilostazol Attenuates AngII-Induced Cardiac Fibrosis in apoE Deficient Mice.

Hada, Yoshiko; Uchida, Haruhito A; Umebayashi, Ryoko; Yoshida, Masashi; Wada, Jun

Hada, Yoshiko; Uchida, Haruhito A; Umebayashi, Ryoko; Yoshida, Masashi; Wada, Jun.

Afiliación

Hada Y; Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.
Uchida HA; Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.
Umebayashi R; Department of Chronic Kidney Disease and Cardiovascular Disease, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.
Yoshida M; Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.
Wada J; Department of Chronic Kidney Disease and Cardiovascular Disease, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Int J Mol Sci ; 23(16)2022 Aug 13.

Article en En | MEDLINE | ID: mdl-36012328

Asunto(s)

Angiotensina II; Cilostazol; Miocardio; Osteopontina; Angiotensina II/metabolismo; Animales; Cilostazol/farmacología; Fibrosis; Humanos; Masculino; Ratones; Ratones Endogámicos C57BL; Ratones Noqueados para ApoE; Miocardio/patología; ARN Mensajero

Palabras clave

angiotensin II; cAMP-PKA; cilostazol; fibrosis; osteopontin

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Angiotensina II / Osteopontina / Cilostazol / Miocardio Límite: Animals / Humans / Male Idioma: En Revista: Int J Mol Sci Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google